Federation des caisses Desjardins du Quebec’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.93K Hold
4,695
﹤0.01% 2390
2025
Q4
$9.3K Hold
4,695
﹤0.01% 2279
2025
Q3
$13.7K Hold
4,695
﹤0.01% 2151
2025
Q2
$8.5K Hold
4,695
﹤0.01% 2101
2025
Q1
$7.04K Hold
4,695
﹤0.01% 2075
2024
Q4
$11.1K Hold
4,695
﹤0.01% 1848
2024
Q3
$138K Buy
4,695
+200
+4% +$4.61K ﹤0.01% 1188
2024
Q2
$55.5K Buy
4,495
+800
+22% +$16.9K ﹤0.01% 1370
2024
Q1
$75K Buy
3,695
+700
+23% +$16.1K ﹤0.01% 1306
2023
Q4
$67.4K Buy
2,995
+500
+20% +$10.6K ﹤0.01% 1227
2023
Q3
$41.5K Hold
2,495
﹤0.01% 1359
2023
Q2
$61.2K Hold
2,495
﹤0.01% 1270
2023
Q1
$60.2K Buy
2,495
+350
+16% +$9.7K ﹤0.01% 1272
2022
Q4
$63.4K Hold
2,145
﹤0.01% 1385
2022
Q3
$89.7K Hold
2,145
﹤0.01% 1349
2022
Q2
$60.3K Hold
2,145
﹤0.01% 1478
2022
Q1
$79.7K Buy
2,145
+495
+30% +$21K ﹤0.01% 1453
2021
Q4
$72.1K Hold
1,650
﹤0.01% 1486
2021
Q3
$102K Buy
1,650
+220
+15% +$18.4K ﹤0.01% 1390
2021
Q2
$122K Buy
1,430
+290
+25% +$15.5K ﹤0.01% 1355
2021
Q1
$51.2K Buy
+1,140
New +$44.8K ﹤0.01% 1541

Other funds holding FLNA

Federation des caisses Desjardins du Quebec's FLNA Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 4,695 shares worth $7.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2390.

Federation des caisses Desjardins du Quebec first reported a position in FLNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $138K in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 4,695 shares of Filana Therapeutics worth $7.93K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2390 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Filana Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Federation des caisses Desjardins du Quebec's Filana Therapeutics position peaked at $138K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.